Comunicati Stampa

A French SCA (Partnership Limited by Shares) with a capital of 56,000,000 EurosHead Offices: La Woestyne 59173 Renescure, FranceBusiness registration number: B 447 250 044 (Dunkerque Registrar of Businesses)FY 2009-2010 annual turnoverFatturato in crescita del 2 . 3%- Vendite sostenute nonostante l incertezza diffusa tra i consumatori- Incremento della quota di mercato per i prodotti di marca- Riuscita integrazione di France Champignon, come da programmi- Avvio delle attività in Brasile nell agosto 2010- Confermato il previsto aumento della redditività operativaAs of June 30th, 2010, consolidated turnover stood at 1,559 . 6 million Euros, compared to 1,523 . 9 million Euros in the previous financial year . At constant foreign exchange rates and on a like-for-like basis, the turnover was down 2 . 2 % . Once again the Bonduelle Group demonstrated its capability for resistance in the face of:- low consumption volumes and significant efforts on consumer retail prices in Western Europe;- the non-materialisation of an economic upturn in Central and Eastern Europe;- an unfavourable USD-to-CAD parity in North America . With the France Champignon acquisition, and the start-up of operations in Brazil, the Group underscores its intention to pursue investments in growing areas . Breakdown of turnover by geographical zone

Consolidated turnover	2009-2010			Q4 2009-2010
(in millions of Euros)		Current	Like for like basis (1)		Current	Like for like basis (1)
		exchange rates			exchange rates
Europe Zone	1174 . 6	+1 . 5 %	- 0 . 8 %	342 . 7	+ 10 . 1%	- 1 . 7 %
Non-Europe Zone	385 . 0	+ 5 . 0 %	- 6 . 1 %	89 . 1	+ 6 . 8 %	- 14 . 9 %
Total	1559 . 6	+ 2 . 3 %	- 2 . 2 %	431 . 8	+ 9 . 4 %	- 4 . 8 %

Breakdown of turnover by processing technology

			Like for like basis (1)
Consolidated turnover	2009-2010	Current		Q4 2009-2010	Current	Like for like basis (1)
(in millions of Euros)		exchange rates			exchange rates
Canned	793 . 7	+ 2 . 9 %	- 2 . 7 %	224 . 9	+ 9 . 7 %	- 7 . 2 %
Frozen	420 . 9	+ 1 . 2 %	- 3 . 9 %	106 . 2	+ 9 . 5 %	- 8 . 1 %
Chilled	345 . 0	+ 2 . 4 %	1 . 1 %	100 . 7	+ 8 . 8 %	+ 4 . 2 %
Total	1559 . 6	+ 2 . 3 %	- 2 . 2 %	431 . 8	+ 9 . 4 %	- 4 . 8 %

(1) Constant exchange rates and scope of consolidationCanned-vegetable salesCanned-vegetable sales closed up 2 . 9 % . When restated to account for consolidation-scope effects (integration of France Champignon sales at April 1, 2010; full-year impact of the November-2008 acquisition of La Corbeille; transfer of apple- and pickle-transformation operations in January 2010) and exchange rate variations, sales had receded by 2 . 7 % . In a western-European market in which retail volumes were generally in negatively oriented, the Bonduelle Group saw increases in branded-product sales in its 3 main markets (France, Germany, and Italy)-thanks notably to significant investments in advertising, major promotional operations, the successful market performance of its innovations (steamed products in France, and the Cassegrain sweet-and-savoury line in particular)-as well as market-share gains in practically all of its territories . Globally, canned-vegetable sales were penalised by the non-materialisation of an upturn in consumption in Central and Eastern Europe, and by voluntary restrictions on customer credit in this region . Frozen-vegetable salesFrozen-vegetable sales rose by 1 . 2 % . When restated to account for consolidation-scope effects (incorporation of France Champignon; full-year impact of the Family Tradition and Omstead Food acquisitions in April and June 2009 respectively; April-2009 deconsolidation of Gelagri s European distributor-brand frozen-vegetables operations) and exchange-rate variations, sales were down by 3 . 9 % . Despite growth in Food Service sales in Western Europe, and market-share gains by Bonduelle-brand products in the French mass retail sector, global frozen-vegetable sales were negatively affected by the impact of a strong Canadian dollar on US sales . Chilled-vegetable salesChilled-vegetable sales were up 2 . 4 %-and 1 . 1 % when restated to account for the incorporation of France Champignon in the scope of consolidation-marking a revival in growth in this technology sector, particularly in terms of volume, in markets which had regained their dynamism . The increase in sales was accompanied by market-share gains by Bonduelle-brand products in both the packaged- and prepared-salads sectors in France . Highlights of the quarterIntegration of France ChampignonThe incorporation of France Champignon s operations is proceeding as planned, i . e . :- Continued rationalisation of production facilities;- Ongoing efforts to achieve administrative synergies and economies of scale (purchasing) . The Group confirms the prospects of a significant improvement in the profitability of this business, and its contribution to an improvement, within 3 years, in the Group s Return on Capital Employed (ROCE) . Transfer of the production facility in StabroekAt the end of June, the Group completed the transfer of the production facility in Stabroek (Belgium), acquired on the occasion of the take-over of La Corbeille, and whose operations were discontinued in FY 2009/2010 . Start-up of the Cristalina site in Brazil confirmed for August 2010With the completion of the first phase of the Cristalina industrial facility-designed for a total production capacity of 50,000 tons-, production (canned peas then corn) is scheduled to begin in August 2010, with the first products appearing on the market in November 2010 . ProspectsDespite a more-difficult-than-anticipated 4th quarter, the Bonduelle Group expects, this year again, to show an increase in operating profitability in FY 2009-2010 . Through asset transfers (Stabroek; apple processing operations) and careful management of working capital requirements, the Group expects to improve its debt ratio (135 % at June 30, 2009), despite the end-of-year acquisition of France Champignon . With poor production campaigns in certain regions (high temperatures), the non-materialisation of an upturn in consumption in Western, Central and Eastern Europe, and the absorption of an overall excess inventory both in Europe and North American markets, the Group is intent on redoubling efforts to adapt its cost structure, while pursuing a selective innovation and investment policy in growth zones . The acquisition of France Champignon opens new and significant prospects forgrowth in profitability, and with its healthy financial situation, the Bonduelle Group s remains ever attentive to further acquisition opportunities . Copyright Hugin Questo comunicato é distribuito da Hugin . L emittente è l unico responsabile per il contenuto del comunicato . [CN#168849]

DATI PRINCIPALI PRIMO SEMESTRE 2010- Ordini:2 FALCON (ordini negativi per 56 aeromobili nel primo semestre 2009)- Consegne:45 FALCON (26 FALCON nel primo semestre 2009)5 RAFALE (7 RAFALE nel primo semestre 2009)- Fatturato netto: EUR 1 . 990 milioni, in crescita del 44% rispetto al primo semestre 2009- Utile di gestione: EUR 248 milioni, in crescita del 104% rispetto al primo semestre 2009- Margine operativo: 12 . 4 %, in crescita dell 8 . 7% nel primo semestre 2009- Utile netto (esclusa THALES): EUR 170 milioni, in crescita del 37% rispetto al primo semestre 2009(compresa THALES, utile netto prima dell ammortamento dell attribuzione del prezzo d acquisto (Purchase Price Allocation): 197 milioni E, utile netto dopo l ammortamento dell attribuzione del prezzo d acquisto (Purchase Price Allocation): 141 milioni E)- Margine netto (esclusa THALES): 8 . 5 %, in calo rispetto al 9 . 0% del primo semestre 2009Saint-Cloud, July 29, 2010 - The Board of Directors, which met the day before, chaired by Mr . Charles EDELSTENNE, approved the financial statements for the 1st half year 2010 . These consolidated condensed interim financial statements were reviewed by the statutory auditors who issued an unmodified conclusion . 1 . Message from the Chairman"The 1st half year was characterized by our Group s achievements both in FALCON deliveries and profitability . However, due to the persistent crisis, we are still facing uncertainties:- even though FALCON orders cancellations pace is decreasing, new orders are taking time to pick up again,- the soar in national debts will lead to Defense budgets restrictions, notably in France . As regards RAFALE, we are discussing with several export prospects . They recognized our military aircraft s qualities during its evaluation and we are looking forward to concluding deals . In this context, we still have to improve our productivity . This improvement is essential as our American competitors, despite their competitive advantage implied by favourable E/$ parity, relocate some of their activities in low cost countries . The unpredictability of the worldwide economy has reinforced us in our option of a cautious industrial policy . It also urges us to prepare for the market recovery with the best possible assets: an even more improved competitiveness, cutting edge products and ambitious processes . "2 . Consolidated results2 . 1 Orders1st half year 2010 consolidated orders amounted to EUR 989 million compared to EUR (-)1,126 million in the 1st half year 2009 . Orders booked by the Group over the last 12 months are as follows in EUR millions:

	DEFENSE		FALCON	Total	%
					Export
France	Export
1st half year	178	74	(-)1,378	(-)1,126	N/A
2009	N/A		N/A
1st half year	184	100	705	989	76%
2010	29%		71%

FALCON programs1st half year 2010 orders for new aircraft, minus cancellations, were slightly positive (2 FALCONs) . Due to the crisis, 1st half year 2009 net orders were negative ((-) 56 FALCONs) . Euro amount of FALCON new orders, with respect to the limited number of aircraft ordered, is explained by a favourable E/$ effect . Our order book is valued using the closing E/$ exchange rate and includes currency hedging . As E/$ parity had favourably developped between December 31, 2009 (1 . 44 $/E) and June 30, 2010 (1 . 23 $/E), a favourable differential was taken into account through the Euro amount of new orders . DEFENSE programsOrders were up by 13% . They mainly corresponded to military support and development programs . 2 . 2 Net sales1st half year 2010 consolidated net sales were EUR 1,990 million, up by 44% compared to EUR 1,384 million in the 1st half year 2009 . Consolidated net sales over the last 12 months are as follows in EUR millions:

	DEFENSE		FALCON	Total	%
					Export
France	Export
1st half year	373	106	905	1,384	71%
2009	35%		65%
1st half year	370	118	1,502	1,990	77%
2010	25%		75%

FALCON programsFALCON net sales were up by 66% between the two 1st half years . In particular, 45 brand new aircraft were delivered in the 1st half year 2010 compared to 26 in the 1st half year 2009 . DEFENSE programsDEFENSE France net sales were comparable between the two 1st half years . 5 RAFALEs were delivered to French Air Force and Navy in the 1st half year 2010, compared to 7 in the 1st half year 2009 . This decrease in RAFALE deliveries was offset by a rise in net sales linked to French military support and development programs . DEFENSE export net sales were up by 11% and were linked to military support programs . 2 . 3 Operating income1st half year 2010 consolidated operating income was EUR 248 million, up by 104% compared to the 1st half year 2009 (EUR 121 million) . Operating margin stood at 12 . 4% up from 8 . 7% in the 1st half year 2009 . These improvements were mainly explained by the growth in net sales (and incidentally by better currency hedging: 1 . 29 $/E in the 1st half year 2010 compared to 1 . 31 $/E in the 1st half year 2009) . 2 . 4 Net incomeExcluding THALES, 1st half year 2010(*) net income (total Group and net attributable Group profit) was EUR 170 million, up by 37% compared to 1st half year 2009 (EUR 124 million) . Net margin(*) stood at 8 . 5% down from 9 . 0% in the 1st half year 2009 . The net income included a EUR 16 million net financial expense, compared to a EUR 44 million net financial income in the 1st half year 2009 . This degradation resulted from the following factors:- in the 1st half year 2009, due to THALES acquisition, the Group sold some available-for-sale marketable securities that made a profit of EUR 38 million;- 1st half year 2010 borrowing costs were EUR 17 million compared to EUR 4 million in the 1st half year 2009 . The borrowings were indeed only taken out in May 2009;- the fall in the average yield of cash and cash equivalents . (*) net income including THALES:- net income before amortization of Purchase Price Allocation: EUR 197 million . - net income after amortization of Purchase Price Allocation: EUR 141 million . 3 . Financial structure and balance sheet itemsThe Group has defined a specific indicator, "Available cash", that reflects the Group s total liquidities minus borrowings . It covers the following balance sheet headings:- cash and cash equivalents;- available-for-sale marketable securities (at market value),- borrowings . Consolidated available cash amounted to EUR 2 . 26 billion as of June 30, 2010 compared to EUR 1 . 98 billion as of December 31, 2009 . This rise (EUR + 0 . 28 billion) was notably due to consolidated net cash from operating activities before working capital changes shown in the 1st half year 2010 (EUR + 0 . 35 billion), partially offset by the dividends paid by the Group (EUR (-) 0 . 09 billion) . Owing to numerous deliveries and limited net orders, the fall in inventories and work-in-progress was offset by the fall in customer advances and progress payments on work-in-progress . This led to no change in working capital . Apart from working capital, the major change in the balance sheet regarded hedging instruments, which market value dropped by EUR 0 . 63 billion . This is related to the variation in E/$ closing rate: 1 . 23 $/E as of June 30, 2010 compared to 1 . 44 $/E as of December 31, 2009 . 4 . Group activities1st half year 2010 was marked furthermore by:- continued negotiations for export sales of RAFALE aircraft;- 2010 best industrial prime contractor Quality Trophy awarded to DASSAULT AVIATION by the French Defense Procurement Agency (Délégation Générale pour l Armement);- type certification for FALCON 7X received from the Civil Aviation Administration of China;- certification for FALCON 2000 EX/LX automatic braking;- boosted FALCON aircraft maintenance capacities in Asia;- final assembly of airframe shipsets and first integration tests of the sub systems of the nEUROn unmanned combat aircraft vehicle (UCAV) . This program, led by DASSAULT AVIATION as the project manager, includes five other European partners . 5 . Outlook for 20102010 net sales should be comparable to 2009 net sales, with deliveries of the order of 85 FALCONs and 11 RAFALEs . Owing to the significant number of available-for-sale pre-owned aircraft on a worldwide scale, the Group does not predict a business aviation market recovery in the short term . Please note that FALCON 900 LX has been certified in July 2010 . The Group s financial statements are available at our website: www . dassault-aviation . comContacts : Yves ROBINS (+33 (0) 1 47 11 86 90Copyright Hugin Questo comunicato é distribuito da Hugin . L emittente è l unico responsabile per il contenuto del comunicato . [CN#168852]

Il Consiglio radunatosi il 28 luglio 2010, sotto la presidenza di Mark Inch, ha approvato i conti della società al 30 giugno . Dati consolidati

In milioni di E		1° semestre 2010	1° semestre 2009
Affitti		37 . 4	37 . 1
Utile netto di gestione		30 . 6	30 . 4
Utile netto ricorrente		18 . 2	16 . 4
Rettifiche al fair value e alienazioni		+0 . 4	-73 . 7
Risultato netto		18 . 2	-57 . 9
Cash flow corrente netto		18 . 7	15 . 9
Cash flow corrente netto (in E/azione)*		3 . 4	2 . 9
Distribuzione (in E/azione) *		2**	2
		31/12/2010	31/12/2009
Valore portafoglio escl . diritti di trasferimento (milioni E)		1052 . 3	1044 . 7
NAV liquidazione (in E/azione) *		71 . 8	70 . 0

* number of shares as at 31 December 2009 and as at 30 June 2010 : 5,433,036** interim dividend with payment in cash or shares, at the shareholder s discretionDespite the turbulent macro-economic environment, Société de la Tour Eiffel (STE) has again achieved satisfactory trading results during the first half of 2010, both in terms of leasing on the existing portfolio and delivery of new developments . This performance justifies the company s proven investment strategy and the quality of its portfolio adapted to user demand: modern buildings, secure modest rents, high occupancy levels, robust cash flow and buildings of a manageable size . Modest rental progressionRents increased by 0 . 8 % between the first half of 2009 and 2010 notwithstanding recent property disposals and negative rental indexation . Setting aside asset disposals completed in 2009 and 2010, the progression would have been 3 . 1% . The physical and financial occupancy rates (excluding developments delivered during the first half 2010) remain stable as at 30 June 2010, being respectively 89 . 5% (unchanged) and 90 . 1% (91 . 1% end 2009) . The tenancy profile continued to consolidate through lease renewals and new lettings, representing E 2 . 4 M of annual rent for a floor area of 27,000 m², exclusive of La Poste . With regard to this specific portfolio, the average break date on leases has been extended to 2015 for an annual rental income of approximately E 9M . Negotiations in hand on recently delivered developments are anticipated to further enhance this trend . Rejuvenation of the portfolio and increase in NAVWith 32,000 m² of development deliveries in 2010, the rejuvenation of the portfolio (666,300 m² with 81% in value of offices) continues . The proportion of new or refurbished buildings now represents 59% of which 30% have a green certification . Comprising medium lot sizes (E 17 . 5M average), STE s portfolio stands at E 1,052 . 3M in the consolidated accounts as at 30 June 2010, compared to E 1,044 . 7M at end 2009 . This slight increase results from a combination of value variation (E + 0 . 5M) and expenditure on buildings delivered during the first half 2010 or under construction on 30 June 2010 (E + 15,9M), allowance having been made for 2010 disposals (E - 8 . 8M) . The liquidation NAV has increased from E 70 . 0 as at the 31 December 2009 to E 71 . 8 (+ 2 . 6%) . Finances under controlIn the face of financial market instability and sensitivity towards macro-economic issues, be it in terms of liquidity, credit margins or interest rates volatility, STE has stringently managed its debt level which remains virtually unchanged at E 653M . Increased drawdown occasioned by development activity has been largely offset by reimbursements made possible through asset disposals and by refinancing of the corporate credit line of E 76 . 5M at the end of the first quarter of 2010 . The average cost of finance has reduced further to 3 . 4% (3 . 9 % end 2009), reflecting lower interest rates applicable to the 50% portion of capped, floating rate debt . The company has taken advantage of the low interest rate environment to extend its hedging arrangements, subscribing on favorable terms to E 127M in CAPs and E 80M in SWAPs, covering the extended period from 2010 to 2013 . 2010 interim dividendIn view of these operating results and cash flow status (E 3 . 4 per share, i . e . +17% compared to E 2 . 9 for the first half 2009), the Board decided an interim dividend of E 2 per share, payable in cash or in shares at the shareholder s discretion . In the case of payment in shares, the price at which new shares will be issued has been set at E 42 . 04, corresponding to 90% of the average closing market value for the 20 days prior to 28th July 2010 minus the amount of the final dividend payment . The dividend will be detached on 9th August and payment made on the 6th October 2010; the period granted to shareholders to exercise their option for a payment in cash or in shares is from the 9th August to the 24th September 2010 . OutlookBuoyed by these satisfying half year results, the company aims to continue concentrating on value creation within its property portfolio, whilst optimizing its finances in the wake of current asset disposals, pending the emergence of a more favorable economic cycle conducive to tangible growth . Limited audit procedures on consolidated accounts have been performed and the statutory auditors report is pending . AGENDA:- 6th October 2010: interim dividend payment (in cash or shares)- 9th November 2010: 3rd quarter turnoverAbout Société de la Tour EiffelA " SIIC " quoted on the Euronext Paris Exchange, the company pursues a strategy focused on the ownership and the development of quality office and business space capable of attracting a wide range of tenants in both established and emerging locations . The company s portfolio stands at over 1 billion Euros of assets spread evenly between the Paris area and the regions . Société de la Tour Eiffel is listed on NYSE Euronext Paris (compartment B) - ISIN code: 0000036816 - Reuters : EIFF . PA - Bloomberg : EIFF . FPContactJérôme DESCAMPS, Deputy Managing Director (Finances)Tel: +33 (0)1 53 43 07 06jerome . descamps@societetoureiffel . comWebsite : www . societetoureiffel . comPress ContactJean-Philippe MOCCI, CapmotTel: + 33 (0)1 71 16 19 13 / + 33 (0)6 71 91 18 83jpmocci@cpamot . comCopyright Hugin Questo comunicato é distribuito da Hugin . L emittente è l unico responsabile per il contenuto del comunicato . [CN#168854]

L ottima prestazione del secondo trimestre spinge l utile netto del primo semestre 2010 a EUR 156 milioniComunicato stampa29 luglio 2010For further information, please contact:Jean-Charles Simon / Géraldine Fontaine +33 (0)1 46 98 73 17Communications and Public AffairsAntonio Moretti +44 (0) 203 207 8562Investor Relations DirectorVery strong second quarter performance drives first half 2010 net income to EUR 156 millionGrazie a un secondo semestre che dimostra la capacità del Gruppo di generare un livello elevato di redditività ricorrente con un utile netto di EUR 120 milioni contro EUR 91 milioni del secondo trimestre 2009 (ossia +32%), SCOR registra un utile semestrale netto di EUR 156 milioni contro EUR 184 milioni del 2009 . In the first half 2010, SCOR combined growth, profitability and solvency:- premium income of EUR 3,258 million . This corresponds to a rise of 8% compared to the first half 2009 (+5% at constant exchange rates) excluding equity-indexed annuity business in the USA and after normalising the level of Non-Life business in the first half of 2009 to the annual growth rate of 2009;- net income of EUR 156 million;- half-year net combined ratio of 102 . 8% for SCOR Global P&C thanks to a combined ratio of 97 . 0% in the second quarter of 2010;- operating margin of 6 . 0% for SCOR Global Life;- return on invested assets (excluding funds withheld by cedants) of 4 . 0%;- annualised ROE of 7 . 7%;- shareholders equity of EUR 4 . 2 billion, up 8 . 1% compared to 31 December 2009, i . e . EUR 23 . 2 book value per share;- operating cash flow of EUR 208 million . In addition, the first quarter demonstrated the Group s ability to absorb an abnormally high concentration of natural catastrophes (Chile, Haiti, Xynthia, etc . ) . Denis Kessler, Chairman and Chief Executive Officer of SCOR, comments: "The first half 2010 results once again illustrate the Group s capacity to combine growth, profitability and solvency, whilst maintaining a medium risk appetite . SGPC s renewals reflect the Group s favourable positioning, the first half results confirm our continued profitability and the increase in our shareholders equity further strengthens the Group s financial situation and solvency . "Key figures of the first half of 2010Gross written premiums for Life and Non-Life reach EUR 3,258 million, remaining stable compared to the first half of 2009 when they reached EUR 3,254 million (+0 . 1% but -2 . 7% at constant exchange rates) . This stability is principally due to the unfavourable impact of the planned and deliberate reduction in equity-indexed annuity business and the development of Non-Life reinsurance . Excluding equity-indexed annuities business in the USA and by normalising the level of Non-Life business in the first half of 2009 to the annual growth rate of 2009, premium income grew by 8% compared to the first half of 2009 (+5% at constant exchange rates) . Bolstered by positive renewals, SCOR Global P&C s (SGPC) premium income records growth of +3 . 8% at EUR 1,764 million over the first 6 months of the year (+0 . 5% at constant exchange rates) . SCOR records a net income of EUR 156 million in the first half of 2010, compared to EUR 184 million in the first half of 2009 . In the second quarter alone net income amounted to EUR 120 million compared to EUR 91 million in the second quarter of 2009 . The first half result is impacted by the high level of losses following a series of natural catastrophes, predominantly in the first quarter . However, it has benefited from the improved operating performance of SCOR Global Life (SGL), and greater returns on the investment portfolio under the combined effects of an active asset management policy and lower impairments . The continued recovery of SGPC s US business, which has now demonstrated its capacity to generate recurring profits, allowed the reactivation of the last set of deferred tax assets of the Non-Life entities in the USA for an amount of EUR 29 million at the end of June 2010 . In comparison, net income registered at 30 June 2009 benefited from the reactivation of EUR 100 million in deferred tax assets relating to the same entities during the first quarter 2009 . Earnings per share (EPS) stands at EUR 0 . 87 compared to EUR 1 . 03 at the end of June 2009 . Annualised return on equity (ROE) amounts to 7 . 7% in the first half of 2010, against 10 . 6% recorded for the same period in 2009 . For the first half standalone, annualised ROE totals 11 . 9%, compared to 10 . 5% in the second quarter 2009 . SCOR shareholders equity increases by 8 . 1% during the first half of 2010 to EUR 4 . 2 billion at 30 June 2010, compared to EUR 3 . 9 billion at 31 December 2009 . Book value per share stands at EUR 23 . 2 at 30 June 2010 . SCOR recorded variations in the exchange rate on consolidated net assets of EUR 272 million, compared to EUR 85 million for the first half of 2009 . During the first half, the Group continued to reduce its debt ratio and currently has a leverage position of 10 . 6% compared to 14 . 6% at the end of 2009 . The Annual General Meeting of 28 April 2010 decided on a dividend payment of EUR 1 per share, that is a payout ratio of 48% . It also determined that the 2009 dividend payment could be made either in cash or in new shares issued at EUR 15 . 96 . This option was exercised in the amount of 2,647,517 new shares for a total value of EUR 42 million, split between EUR 21 million of share capital and EUR 21 million of additional paid-in capital . The total sum of dividends distributed for 2009 reached EUR 179 million, EUR 42 million being paid in shares and EUR 137 million in cash . The positive operating cash flow linked to operational business stands at EUR 208 million at 30 June 2010, compared to EUR 308 million for the same period in 2009 . This decrease stems mainly from SGL due to the planned and deliberate reduction in the portfolio of equity-indexed annuity business in the United States . SGPC confirms its projected net combined ratio of less than 100% for the year 2010 excluding exceptional eventsSGPC reports gross written premiums of EUR 1,764 million for the first half of 2010, compared to EUR 1,699 million in 2009, representing an increase of 3 . 8% . This increase represents 0 . 5% at constant exchange rates compared to 2009, a year marked by a sharp rise in gross written premiums in the first half . Relative to normalised growth in the first half of 2009 on the basis of the increase registered over the full year 2009, the first half of 2010 marks an increase of 8% in gross written premiums compared to the first half of 2009 . The net combined ratio stands at 102 . 8% in the first half of 2010, compared to 108 . 6% in the first quarter of 2010 and 97 . 5% in the first half of 2009 . Natural catastrophes contributed 13 . 1 points of net combined ratio over the half year (compared to 20 . 2 points in the first quarter 2010), whilst the second quarter saw natural catastrophe losses in line with budget (6 points) . The estimated total net cost for the earthquakes in Chile and Haiti and hurricane Xynthia remains unchanged relative to the figures communicated with the first quarter results . Attritioned losses are down 1 . 5 points; this decrease illustrates the dynamic management of the portfolio and the expected improvement in technical results following the renewals of the last two years . Excluding exceptional events and subject to natural catastrophe losses not exceeding budget for the third and fourth quarters of the year, the net combined ratio for 2010 should be below 100% . The excellent P&C and Specialty treaty renewals at the end of June and in July 2010 are characterised by premium volume growth of 19% at constant exchange rates, totalling EUR 245 million, in line with the expected underwriting profitability objective in 2010 . These renewals concern around 10% of the total annual volume of treaty premiums . Following these renewals, SGPC maintains its estimation of the amount of gross premiums in a range between EUR 3 . 45 and EUR 3 . 5 billion for 2010 . SCOR Global Life (SGL) records an operating margin of 6 . 0% in the first half of 2010 compared to 5 . 1% in the first half of 2009In the first half of 2010, SGL s gross written premiums totalled EUR 1,494 million compared to EUR 1,555 million for the same period 2009 (a decrease of 3 . 9%) . Gross written premiums excluding equity-indexed annuity business in the US amount to EUR 1,457 million compared to EUR 1,356 million in the first six months of 2009, representing an increase of 7 . 6% . This growth stems mainly from Critical Illness and Long-Term lines and from new business in North America, the UK & Ireland . The Life operating margin for the first six months ended 30 June 2010 amounted to 6 . 0% (compared to 5 . 1% for the same period 2009) . This increase of 0 . 9 percentage points stems mainly from improvements in the profitability in different business segments and due to a positive development of the investment income . SCOR Global Investments (SGI) maintains its "rollover" investment strategy and posts a sharp increase in net return on invested assetsIn a context of low interest rates and greater volatility in the financial markets, the Group is maintaining a "rollover strategy" for its fixed income portfolio in order to have significant financial cash flows to reinvest in the event of a sudden change in the economic and financial environment, whilst seizing market opportunities in the short term . This investment policy led to net realised gains of EUR 108 million during the first two quarters of 2010 . SCOR posts a net return on investments (excluding funds held by cedants) of 4 . 1% in the second quarter 2010, compared to 3 . 9% in the first quarter 2010 . Consequently, SCOR has recorded a net return on invested assets over the first 6 months of the year (excluding funds withheld by cedants) of 4 . 0%, a significant rise compared to the first half of 2009 (1 . 0%) . The impact of impairments is limited to EUR 52 million in the first half of 2010 compared to EUR 184 million in the first half of 2009 . Taking into account the funds withheld by cedants, net return on invested assets amounts to 3 . 4% over the first half of 2010, compared to 1 . 4% in the same period of 2009 . Net investments, including cash, stand at EUR 21,663 million at 30 June 2010, compared to EUR 19,969 million at 31 December 2009 . At 30 June 2010, the Group s investments consist of bonds (48 . 1%), funds withheld by cedants (37 . 4%), cash and short-term investments (6 . 3%), equities (4 . 4%), real estate (2 . 1%) and other alternative investments (1 . 7%) . Liquidity reaches EUR 1 . 4 billion at 30 June 2010, compared to EUR 1 . 7 billion at 31 December 2009 . SCOR s high-quality fixed income portfolio (average rating AA) maintains a relatively short duration of 3 . 4 years (excluding cash and short-term investments), down slightly compared to 31 December 2009 (3 . 7 years) . Investments in inflation-linked bonds amount to EUR 1,022 million at 30 June 2010 . ** *Key figures (in EUR millions)

		H1 2010	H1 2010	H1 2009	H1 2009	Q2 2010		Q2 2009
		(unaudited)	(unaudited)	(unaudited)	(unaudited)	(unaudited)		(unaudited)
Gross written premiums	3 258	3 254	1 645	1 693
Non-Life gross written premiums	1 764	1 699	855	831
Life gross written premiums	1 494	1 555	790	862
Operating income excl . impairments	234	312	178	159
Net income	156	184	120	91
Investment income	356	149	184	153
Net Return on Investments	4 . 0%	1 . 0%	4 . 1%	3 . 6%
Net Return on Assets	3 . 4%	1 . 4%	3 . 4%	3 . 1%
Non-Life combined ratio	102 . 8%	97 . 5%	97 . 0%	95 . 8%
Non-Life technical ratio	96 . 0%	91 . 0%	89 . 8%	89 . 3%
Non-Life cost ratio	6 . 8%	6 . 5%	7 . 2%	6 . 5%
Life operating margin	6 . 0%	5 . 1%	6 . 0%	5 . 5%
Return on Equity (ROE)	7 . 7%	10 . 6%	11 . 9%	10 . 5%
Basic EPS (EUR)	0 . 87	1 . 03	0 . 67	0 . 51
		H1 2010	H1 2010	H1 2009	H1 2009	Q2 2010		Q2 2009
		(unaudited)	(unaudited)	(unaudited)	(unaudited)	(unaudited)		(unaudited)
Investments (excl . participations)	21 663	19 542
Reserves (gross)	23 194	20 848
Shareholders equity	4 216	3 635
Book value per share (EUR)	23 . 2	20 . 2

Forward-looking statementsSCOR does not communicate "profit forecasts" in the sense of Article 2 of (EC) Regulation n°809/2004 of the European Commission . Thus, any forward- . looking statements contained in this communication should not be held as corresponding to such profit forecasts . Information in this communication may include "forward-looking statements", including but not limited to statements that are predictions of or indicate future events, trends, plans or objectives, based on certain assumptions and include any statement which does not directly relate to a historical fact or current fact . Forward-looking statements are typically identified by words or phrases such as, without limitation, "anticipate", "assume", "believe", "continue", "estimate", "expect", "foresee", "intend", "may increase" and "may fluctuate" and similar expressions or by future or conditional verbs such as, without limitations, "will", "should", "would" and "could . " Undue reliance should not be placed on such statements, because, by their nature, they are subject to known and unknown risks, uncertainties and other factors, which may cause actual results, on the one hand, to differ from any results expressed or implied by the present communication, on the other hand . Please refer to SCOR s document de référence filed with the AMF on 3 March 2010 under number D . 10-00085 (the "Document de Référence"), for a description of certain important factors, risks and uncertainties that may affect the business of the SCOR Group . As a result of the extreme and unprecedented volatility and disruption of the current global financial crisis, SCOR is exposed to significant financial, capital market and other risks, including movements in interest rates, credit spreads, equity prices, and currency movements, changes in rating agency policies or practices, and the lowering or loss of financial strength or other ratings . Copyright Hugin Questo comunicato é distribuito da Hugin . L emittente è l unico responsabile per il contenuto del comunicato . [CN#168855]

- Le vendite nette consolidate sono state positive e sono aumentate nel secondo trimestre, guidate da ottime prestazioni in Legal e Markets- Ricavi ricorrenti nel secondo trimestre in calo dell 1% prima della conversione valutaria- Ricavi della divisione Professional in crescita del 2% prima della conversione; ricavi della divisione Markets in calo del 3% prima della conversione- Utile di gestione sottostante pari a $ 655 milioni, in calo del 17%- EPS rettificato pari a $ 0 . 47 contro $ 0 . 58 nello stesso periodo dell esercizio precedente- Free cash flow sottostante per ai $ 751 milioni, in calo dell 11%- Riconferma delle prospettive 2010NEW YORK, 29 luglio 2010 - Thomson Reuters (TSX / NYSE: TRI), leader al mondo nella fornitura di informazioni per aziende e professionisti, ha reso oggi noti i risultati del secondo trimestre conclusosi il 30 giugno 2010 . La società ha riferito ricavi continuativi pari a $ 3 . 2 miliardi, utili di gestione sottostanti pari a $ 655 milioni, un margine operativo del 20,4% e free cash flow sottostante pari a $ 751 milioni . "I am pleased with the continuing progress the company has made in the first half of the year . While our markets are only slowly improving, we have seen accelerating results in terms of revenues, net sales and customer uptake of our new products," said Thomas H . Glocer, chief executive officer of Thomson Reuters . "Based on these encouraging trends, we expect that Thomson Reuters will return to revenue growth in the third quarter . ""We attribute our expected return to growth to our decision not to cut investment in innovation and new product platforms in 2010 . While investments in the launch of products like WestlawNext, Thomson Reuters Eikon and the ONESOURCE global tax workstation are still expected to suppress margins by some 100 basis points in 2010, they will enable us to drive growth, strengthen our competitive position and improve margins for years to come . "Consolidated Financial Highlights

	Three Months Ended June 30,
	(Millions of U . S . dollars, except EPS and profit margin)
IFRS Financial Measures	2010	2009	Change
Revenues	$3,216	$3,293	-2%
Operating profit	$435	$475	-8%
Diluted earnings per share (EPS)	$0 . 35	$0 . 38	-8%
Cash flow from operations	$888	$1,006	-12%
Non-IFRS Financial Measures[1]	2010	2009	Change	Change Before Currency
Revenues from ongoing businesses	$3,216	$3,275	-2%	-1%
Underlying operating profit	$655	$792	-17%	-12%
Underlying operating profit margin	20 . 4%	24 . 2%	-380bp
Adjusted earnings per share (EPS)	$0 . 47	$0 . 58	-19%
Underlying free cash flow	$751	$846	-11%

[1] These and other non-IFRS financial measures are defined and reconciled to the most directly comparable IFRS measure in the tables appended to this news release . Additional information is provided in the explanatory note at the end of this news release . - Revenues from ongoing businesses were $3 . 2 billion, a decrease of 2% after currency and a decrease of 1% before currency . Good growth in Enterprise, Legal s subscription businesses and Tax & Accounting was offset by expected softness in Legal print and non-subscription revenues and a decline in Sales & Trading and Investment & Advisory revenues due to flow-through from prior-year negative net sales . - Underlying operating profit declined 17%, attributable to lower revenues, product mix, previously announced investments and unfavorable currency movements . Underlying operating profit declined 12% before currency . - Adjusted EPS was $0 . 47 compared to $0 . 58 in the prior-year period . The decline was largely attributable to lower underlying operating profit . - Underlying free cash flow was $751 million, a decline of 11% versus the prior-year period . - Integration and legacy savings programs continue to progress well, achieving run-rate savings of $1 . 3 billion towards a previously announced goal of $1 . 6 billion of run-rate savings by the end of 2011 . CONTACT

MEDIA	INVESTORS
Calvin Mitchell	Frank Golden
Senior Vice President, Corporate Affairs	Senior Vice President, Investor Relations
+1 646 223 5285	+1 646 223 5288
calvin . mitchell@thomsonreuters . com	frank . golden@thomsonreuters . com
Victoria Brough
Head of External Affairs, EMEA
+44 (0)207 542 8763
victoria . brough@thomsonreuters . com

Please find the complete release including tables under the link below:http://hugin . info/142273/R/1434666/380231 . pdfCopyright Hugin Questo comunicato é distribuito da Hugin . L emittente è l unico responsabile per il contenuto del comunicato . [CN#168888]

L offerta Lectra di soluzioni per il taglio dei pellami si amplia per soddisfare al meglio le molteplici esigenze delle imprese produttrici che operano sui mercati delle automobili, dei mobili, degli articoli di pelletteria e delle calzature tecniche . Paigi, 27 luglio 2010 - Lectra, leader mondiale delle soluzioni tecnologiche integrate per le industrie che utilizzano materiali soft - tessuti, pellami, tessuti industriali e materiali compositi - ha annunciato oggi il lancio di due nuove linee di soluzioni per il taglio dei pellami: la linea PLH, progettata specificamente per i mercati degli articoli di pelletteria e delle calzature tecniche, e la linea PLF, disponibile in due versioni: PLF Auto e PLF Mobili . Frutto di importanti investimenti in R&S, queste due nuove linee di tagliatrici ampliano l offerta Lectra di soluzioni per i pellami . Specially designed for small-run production, the PLF and PLH ranges benefit from know-how developed by Lectra for its high-end systems . Leather: industries facing numerous constraintsIn an economic context marked by a sharp increase in leather prices and frequent outsourcing and relocation, both of which affect production and logistics management, manufacturers in leather markets are subject to increasingly tight constraints in terms of sourcing costs, stock management and product availability . For these manufacturers, it is more important than ever to reduce manufacturing times while maintaining a good ratio between quality and return on investment, regardless of how and where they manufacture their products . The ability to significantly save on materials and improve productivity at the leather cutting stage has an immediate and major impact on production costs, while helping to create better-quality products at lower costs and in line with consumer needs . In order to address a wide variety of customers with extremely diverse profiles-in terms of market, organizational structure, challenges and constraints-Lectra has extended its leather offer with the PLF and PLH ranges . Due to their great versatility, these ranges can cater equally to the needs of SMEs producing small and medium runs and non-OEM products for the automotive industry, as well as for the prototyping and pre-production departments of larger groups . "These new cutting solutions draw on the expertise we have acquired over more than 15 years working with major players in the leather markets-leather goods, technical footwear, automotive and furniture," explained Daniel Harari, Lectra CEO . "In the leather industry, every manufacturer is unique and faces its own specific problems . The hides used differ from one customer to another, as do their requirements in terms of nestings, their organizational constraints, their specific needs, etc . Our strategy is to support our customers through teams of experts and the most advanced technologies in order to optimize their working processes . "PLF and PLH: important assets for manufacturers in leather marketsThe PLF and PLH ranges give manufacturers who need to cut leather a unique advantage over the rest of the market . These solutions boast the largest usable leather-cutting area, for all types of hide, measuring 3m by 3 . 2m on the PLF and 3m by 1 . 3m on the PLH . This ability to handle and process the largest usable area on whole hides (or half-hides) in one go, combined with powerful software based on sophisticated algorithms, enables operators to achieve optimal nesting efficiency and gives manufacturers a particular competitive advantage in terms of optimizing materials . At mid-range prices, savings can reach E100,000 per year, using either the PLF or the PLH . The PLF and PLH ranges incorporate Lectra s "combined" nesting-making method, a powerful, collaborative process that allows operators to choose the nesting-making method best suited to their type of production . They can use the interactive mode when the quality or symmetry requirements of items to be produced demand that specific areas of leather be chosen based on the hide s characteristics (grain type and quality, levelness, handle, etc . ), and automatic mode when working on less critical parts . The combined nesting-making method meets a fundamental need of manufacturers, as they can now process all types of leather-natural, semi-aniline, grainy or slightly rectified-and, at any time in the cycle, choose the most suitable nesting-making method for their type of production, regardless of product and model style or site organization, achieving immeasurable savings in time and materials . "Lectra s PLH cutting solution has enabled us to reduce leather consumption by 15 to 20% . We have also increased our productivity and improved our bag production process . In addition, we have noticed a speedy return on investment with the PLH, mainly due to the optimization of our material consumption," explained Francisco Hernández, Operations Director, Sociedad Textil Lonia (Spain, Purificacion Garcia brand) . The PLF and PLH ranges provide the added advantage of automating the cutting process, which has an impact on costs incurred through poor quality by significantly reducing waste due to badly-cut parts . In this way, the product cycle is shortened and hide consumption optimized, all the while maintaining consistent product quality . Other sources of savings can be found in the simplified and optimized use of the solutions by teams in charge of their management . Particular care was taken with ergonomics in order to make the PLF and PLH cutters as simple to use as possible, even for operators with little training . The fact that the solutions are quick and easy to learn is particularly valuable, especially in emerging countries and countries with high team turnover . In other countries, it allows operators to make better use of their skills by enabling them to focus more on added-value activities . The PLF and PLH ranges also incorporate production log and data management functions, which record the characteristics of hides used as cutting proceeds . Operators therefore have a log of data entered automatically when the hide was scanned . The data log relates to the hide s surface area, leather quality, the number of flaws detected, nesting choices made, hide consumption per model, etc . This valuable information makes it easier to make an objective comparison of hides delivered by suppliers and improve quality control for raw materials purchased . A customized support and monitoring service provided by Lectra s expertsThrough the wealth of expertise it has acquired in the leather markets during the last 15 years, Lectra now has extensive know-how to place at the disposal of its customers in order to advise them on best practices, regardless of their business model or company type . The "tailor-made" support provided by Lectra s experts includes a preliminary evaluation phase, implementation, customized training of teams and regular follow-up for customers, guaranteeing the most efficient use of the leather cutting solutions and a better return on investment . About LectraLectra is the world leader in integrated technology solutions that automate, streamline and accelerate product design, development and manufacturing processes for industries using soft materials . Lectra develops the most advanced specialized software and cutting systems and provides associated services to a broad array of markets including fashion (apparel, accessories, footwear), automotive (car seats and interiors, airbags), furniture, as well as a wide variety of other market sectors, such as the aeronautical and marine industries, wind power and personal protective equipment . Lectra serves 23,000 customers in more than 100 countries with 1,400 employees and $214 million in 2009 revenues . The company is listed on Euronext Paris . For more information, please visit www . lectra . comCopyright Hugin Questo comunicato é distribuito da Hugin . L emittente è l unico responsabile per il contenuto del comunicato . [CN#168735]

I rendiconti finanziari al 30 giugno 2010 sono stati esaminati dal Consiglio di sorveglianza, riunitosi il 27 luglio 2010 . 2° TRIMESTRE 2010: RITORNO A UNA CRESCITA ORGANICA DELLE VENDITE, MIGLIORAMENTO SIGNIFICATIVO DELLA REDDITIVITÀOBIETTIVI 2010 RIVISTI AL RIALZO- Vendite in aumento del 2,3% nel secondo trimestre (su base comparabile e a parità di numero di giorni) dopo sei trimestri consecutivi di flessione- Europa: crescita nell arco dell intero trimestre (+3,6%)- Nord America: lieve flessione su base trimestrale (-1,7%), ma crescita a giugno- Asia-Pacifico: forte crescita (+9,9%) stimolata da Cina e Australia- EBITA in aumento del 39% e margine EBITA1 in crescita di 110 punti base nel 2° trimestre- Miglioramento del margine lordo1- Continued focus on cost control- Full-year targets revised upwards:- Slight increase in sales on a constant and same-day basis- Adjusted EBITA margin above 4 . 5%- Free cash flow before interest & tax above E400m

At June 30	Q2 2010	YoY Change	H1 2010	YoY Change
On a reported basis
Sales (Em)	3,047 . 0	+8 . 9%	5,744 . 6	+2 . 4%
% change organic same-day		+2 . 3%		-1 . 6%
EBITA (Em)	148 . 0	+39 . 2%	257 . 4	+36 . 4%
EBITA margin (as a % sales )	4 . 9%	+110bps	4 . 5%	+110bps
Operating income (Em)	124 . 9	+100 . 5%	214 . 0	+111 . 5%
Free cash flow before interest and tax paid (Em)	156 . 2	-31 . 7%	182 . 9	-53 . 9%
Net debt end of period (Em)			2,534 . 7	-6 . 4%
On a constant and adjusted basis1
Gross profit (Em)	739 . 6	+3 . 6%	1,409 . 1	-0 . 8%
Gross margin (as a % sales)	24 . 3%	+10bps	24 . 5%	+10bps
EBITA (Em)	142 . 8	+33 . 7%	244 . 5	+24 . 8%
EBITA margin (as a % sales )	4 . 7%	+110bps	4 . 3%	+90bps

1 Constant and adjusted = at comparable scope of consolidation and exchange rates, excluding the non-recurring effect related to changes in copper-based cables price and before amortization of purchase price allocation; an extract of financial statements is presented in Appendix . Jean-Charles Pauze, Chairman of the Management Board and CEO, said:"In an environment that remains challenging, Rexel reached a turning point in the past quarter with a return to organic growth, after six consecutive quarters of decline . We also significantly improved our profitability and our indebtedness ratio fell below 4 . 0x at the end of June . Our better-than-expected Q2 performance and improved prospects for the second half lead us to revise upwards our full-year targets . Rexel remains focused on implementing its strategy aimed at seizing business opportunities in key growth segments such as energy efficiency - notably lighting -, renewable energies and major projects while reinforcing its market leadership . "Financial review for the period ended June 30, 2010Unless otherwise stated, all comments are on a constant and adjusted basis and, for sales, at same number of working daysSales grew in Q2 (+2 . 3% on a constant and same-day basis) after six consecutive quarters of decline: Europe was positive throughout the quarter (+3 . 6%), North-America remained slightly negative (-1 . 7%) but was positive in June and Asia-Pacific posted solid growth (+9 . 9%), driven by China and AustraliaIn the second quarter, Rexel recorded sales of E3,047 . 0 million, up 2 . 3% on a constant basis and same number of working days . It was the first quarter of growth after six consecutive quarters of decline . Although activity remained low compared to the "pre-crisis" levels, organic evolution in Q2 confirms an improvement in trends . Branch network streamlining (114 branches closed over the last 12 months, of which 13 in the quarter) represented a negative impact on sales of 0 . 7 percentage points, while the rise in copper-based cable prices had a positive impact of 3 . 3 percentage points . On a reported basis, sales were up 8 . 9% . They included (i) a positive currency impact of E177 . 5 million (mainly due to the appreciation of the Canadian and Australian dollars) and (ii) a negative impact from divestitures net of acquisitions of E22 . 6 million (related to the disposals of HCL Asia and Haagtechno) . In the first half, sales were down 1 . 6% on a constant basis and same number of working days with a negative impact of 1 . 2 percentage points due to branch network streamlining and a positive impact of 3 . 2 percentage points due to the rise in copper-based cable prices . On a reported basis, sales were up 2 . 4%, including (i) a positive currency impact of E235 . 0 million and (ii) a negative impact from divestitures net of acquisitions of E30 . 0 million . Europe (59% of sales): in the quarter, sales were up 3 . 6% (after -3 . 4% in Q1 2010) . Sales were flat (+0 . 1%) in the half . In the quarter, Germany continued recording strong growth (+28 . 7%), boosted by photovoltaic sales . Austria and Switzerland also posted solid growth of 13 . 1% and 7 . 8% respectively . France, which resumed growth as of March, recorded a 3 . 9% rise in sales and the UK recorded a limited drop of 2 . 0%, representing an improvement over the 4 . 2% drop in Q1 . Scandinavian countries returned to growth with an overall 3 . 4% increase (vs . a 7 . 3% drop in Q1) . In its three major countries, France, the UK and Germany (representing 61% of the Group s European sales), Rexel estimates it continued to gain market share . North America (29% of sales): in the quarter, sales were down 1 . 7% (after -13 . 5% in Q1 2010) but sales evolution was positive in June, both in the US and in Canada . North American sales were down 7 . 3% in the half . In the US, sales were down only 3 . 6% in the quarter (after -16 . 7% in Q1 2010) . Branch closures (30 branches closed over the last 12 months, i . e . an 8% reduction) represented a negative impact on sales of 3 . 1 percentage points . While activity remained low and the commercial end-market continued to deteriorate, the industrial and residential end-markets continued to show signs of improvement . In Canada, which resumed growth as of April, sales were up 3 . 1% in the quarter (after -4 . 5% in Q1 2010), mainly supported by the commercial and manufacturing sectors and by a 46% increase in the energy savings segment . Asia-Pacific (9% of sales): in the quarter, sales were up 9 . 9% (after +7 . 4% in Q1 2010) . Sales were up 8 . 7% in the half . This growth was mainly driven by the strong development of sales in China, which grew organically by 27 . 6% in the quarter . In Australia, which resumed growth as of March, sales were up 7 . 4% in the quarter (after +1 . 0% in Q1 2010), driven by the project activity . Other (3% of sales): sales were down 1 . 3% in the quarter (after -6 . 7% in Q1 2010) and down 4 . 1% in the half . Significant improvement in profitability since the beginning of the year: EBITA margin1 up 90bps; reported EBITA rose 36%In the quarter, EBITA margin[1] stood at 4 . 7%, vs . 3 . 6% in Q2 2009 (+110bps year-on-year) . In the half, it stood at 4 . 3% vs . 3 . 4% in H1 2009 . This 90bps improvement reflected:- A 10bps improvement in gross margin1 (24 . 5% vs . 24 . 4% in H1 2009), mainly driven by Europe and North America,- The ongoing effects of cost-cutting measures implemented over the previous quarters: distribution and administrative expenses[2] in the half were down 4 . 9% year-on-year and represented 20 . 3% of sales vs . 21 . 1% in H1 2009 . Reported EBITA reached E148 . 0 million in the quarter, up 39 . 2% vs . Q2 2009, and E257 . 4 million in the half, up 36 . 4% vs . H1 2009 . Operating income more than doubled; strong increase in net incomeAmortization of purchase price allocation amounted to E12 . 3 million in the half (vs . E9 . 6 million in H1 2009) . Other income and expenses amounted to a net charge of E31 . 1 million in the half (of which E29 . 5 million of restructuring costs) vs . a net charge of E77 . 8 million in H1 2009 (of which E53 . 0 million of restructuring costs) . As a result, operating income in the half more than doubled to E214 . 0 million vs . E101 . 2 million in H1 2009, reflecting the 36 . 4% rise in EBITA and reduced restructuring costs . Net financial expenses amounted to E52 . 8 million in the quarter, in line with the E50 . 7 million recorded in the previous quarter . In the half, they amounted to E103 . 5 million vs . E74 . 7 million in H1 2009 . This increase reflected a higher effective interest rate (7 . 1% compared to 5 . 1% in H1 2009), mainly due to the Senior Credit margin step-up since August 1st, 2009 . It also included the amortization of financing fees generated by the July amendment to the Senior Credit Agreement and the December refinancing operations (Bond issue and full refinancing of Senior Credit) . After share of profit / loss in associates (profit of E0 . 4 million) and after income tax (charge of E18 . 5 million vs . E8 . 5 million in H1 2009), net income in the half amounted to E92 . 4 million vs . E18 . 0 million in H1 2009 . Tight control of indebtedness despite seasonality, unfavourable currency effect and one-off impact of Ceteco litigation settlementFree cash flow before interest and tax[3] in the half amounted to E182 . 9 million . It included:The one-off impact of the settlement of litigation concerning the Dutch company Ceteco for E29 . 8 million that was paid in March and already disclosed in Q1 2010,The effect of business seasonality on working capital, the change of which represented a cash outlay of E20 . 4 million . Working capital stood at 11 . 3% of sales at the end of June, vs . 11 . 4% at the end of June 2009 . After E87 . 0 million of net interest paid and E27 . 9 million of income tax paid, net debt stood at E2,534 . 7 million, flat vs . the end of the previous quarter (E2,539 . 4 million at March 31, 2010) and increased by E133 . 5 million vs . December 31, 2009 . This increase reflected a E198 . 4 million negative currency impact . Indebtedness ratio (Net financial debt / EBITDA), as calculated under the Senior Credit Agreement terms, stood at 3 . 92x at the end of June (vs . 4 . 32x at the end of December), well below the covenant limit of 5 . 15x and below 4 . 00x, leading to a 50bps reduction of the margin applicable to the Senior Credit Agreement . In accordance with the commitments undertaken in the Senior Credit Agreement, an indebtedness ratio below 4 . 00x at the end of the year allows Rexel to resume payment of a dividend in 2011 . OutlookBetter-than-expected performance since the beginning of the year and improved prospects for the second-half of the year lead the Group to revise upwards its full-year targets:Sales should slightly increase on a constant and same-day basis (vs . February guidance of a low single-digit drop on a constant and same-day basis),Adjusted EBITA margin should be above 4 . 5% (vs . February guidance of an improvement over the 4 . 0% recorded in 2009),Free cash-flow before interest and tax should be above E400 million (vs . February guidance of around E400 million) . Financial informationRexel announced that its half-yearly financial report for the period ended June 30, 2010 is available to the public and has been filed with the French Autorité des Marchés Financiers . The half-yearly financial report is available on the Internet site of Rexel (www . rexel . com) in the "Regulated information" section . A slideshow of the second quarter and first-half 2010 results is also available on the Company s website . CalendarNovember 10, 2010: Third-quarter and 9-month 2010 resultsDecember 2 & 3, 2010: Investor DayContacts

Financial Analysts / Investors	Press
Marc MAILLET	Brunswick: Thomas KAMM
( +33 1 42 85 76 12	( +33 1 53 96 83 92
mmaillet@rexel . com	tkamm@brunswickgroup . com
Florence MEILHAC	Brunswick: Olivier ARMENGAUD
( +33 1 42 85 57 61	( +33 1 53 96 83 83
fmeilhac@rexel . com	oarmengaud@brunswickgroup . com

Appendix 1Segment reporting - Constant and adjusted basis (*)(*) Constant and adjusted = at comparable scope of consolidation and exchange rates, excluding the non-recurring effect related to changes in copper-based cables price and before amortization of purchase price allocation; the non-recurring effect related to changes in copper-based cables price was, at the EBITA level:- a profit of E6 . 5 million in Q2 2009 and a profit of E5 . 2 million in Q2 2010,- a profit of E3 . 6 million in H1 2009 and a profit of E12 . 9 million in H1 2010 . Group

	Constant and adjusted basis (Em)	Q2 2009	Q2 2010	Change	H1 2009	H1 2010	Change
Sales		2,954 . 0	3,047 . 0	+3 . 2%	5,813 . 9	5,744 . 6	-1 . 2%
	on a constant basis and same days			+2 . 3%			-1 . 6%
Gross profit		714 . 0	739 . 6	+3 . 6%	1,420 . 6	1,409 . 1	-0 . 8%
	as a % of sales	24 . 2%	24 . 3%	+10bps	24 . 4%	24 . 5%	+10bps
Distribution & adm . expenses (incl . depreciation)		(607 . 2)	(596 . 9)	-1 . 7%	(1,224 . 6)	(1,164 . 6)	-4 . 9%
EBITA		106 . 8	142 . 8	+33 . 7%	196 . 0	244 . 5	+24 . 8%
	as a % of sales	3 . 6%	4 . 7%	+110bps	3 . 4%	4 . 3%	+90bps
Headcount (end of period)		29,885	27,840	-6 . 8%	29,885	27,840	-6 . 8%

Europe

	Constant and adjusted basis (Em)	Q2 2009	Q2 2010	Change	H1 2009	H1 2010	Change
Sales		1,657 . 5	1,744 . 5	+5 . 3%	3,324 . 2	3,365 . 3	+1 . 2%
	on a constant basis and same days			+3 . 6%			+0 . 1%
o/w	France	544 . 7	584 . 8	+7 . 4%	1,116 . 6	1,152 . 7	+3 . 2%
	on a constant basis and same days			+3 . 9%			+0 . 8%
	United Kingdom	224 . 5	220 . 0	-2 . 0%	462 . 3	447 . 8	-3 . 1%
	on a constant basis and same days			-2 . 0%			-3 . 1%
	Germany	186 . 4	243 . 6	+30 . 7%	358 . 0	443 . 0	+23 . 7%
	on a constant basis and same days			+28 . 7%			+22 . 7%
	Scandinavia	199 . 5	208 . 4	+4 . 5%	397 . 9	392 . 4	-1 . 4%
	on a constant basis and same days			+3 . 4%			-1 . 9%
Gross profit		423 . 4	447 . 3	+5 . 6%	858 . 0	873 . 1	+1 . 8%
	as a % of sales	25 . 5%	25 . 6%	+10bps	25 . 8%	25 . 9%	+10bps
Distribution & adm . expenses (incl . depreciation)		(359 . 0)	(343 . 5)	-4 . 3%	(731 . 0)	(687 . 4)	-6 . 0%
EBITA		64 . 4	103 . 8	+61 . 1%	127 . 0	185 . 6	+46 . 2%
	as a % of sales	3 . 9%	5 . 9%	+200bps	3 . 8%	5 . 5%	+170bps
Headcount (end of period)		18,247	16,664	-8 . 7%	18,247	16,664	-8 . 7%

North America

	Constant and adjusted basis (Em)	Q2 2009	Q2 2010	Change	H1 2009	H1 2010	Change
Sales		935 . 2	919 . 2	-1 . 7%	1,807 . 9	1,665 . 3	-7 . 9%
	on a constant basis and same days			-1 . 7%			-7 . 3%
	o/w United States	673 . 1	649 . 0	-3 . 6%	1,315 . 5	1,175 . 1	-10 . 7%
	on a constant basis and same days			-3 . 6%			-10 . 0%
	Canada	262 . 0	270 . 3	+3 . 1%	492 . 3	490 . 3	-0 . 4%
	on a constant basis and same days			+3 . 1%			-0 . 4%
Gross profit		201 . 4	198 . 1	-1 . 6%	389 . 4	359 . 9	-7 . 6%
	as a % of sales	21 . 5%	21 . 6%	+10bps	21 . 5%	21 . 6%	+10bps
Distribution & adm . expenses (incl . depreciation)		(174 . 8)	(171 . 4)	-2 . 0%	(348 . 8)	(321 . 0)	-8 . 0%
EBITA		26 . 6	26 . 7	+0 . 4%	40 . 6	38 . 8	-4 . 4%
	as a % of sales	2 . 8%	2 . 9%	+10bps	2 . 2%	2 . 3%	+10bps
Headcount (end of period)		7,949	7,534	-5 . 2%	7,949	7,534	-5 . 2%

Asia-Pacific

	Constant and adjusted basis (Em)	Q2 2009	Q2 2010	Change	H1 2009	H1 2010	Change
Sales		263 . 0	287 . 4	+9 . 3%	481 . 8	523 . 1	+8 . 6%
	on a constant basis and same days			+9 . 9%			+8 . 7%
o/w	Australia	168 . 9	179 . 7	+6 . 4%	318 . 4	331 . 2	+4 . 0%
	on a constant basis and same days			+7 . 4%			+4 . 4%
	New-Zealand	35 . 6	35 . 1	-1 . 5%	65 . 0	64 . 1	-1 . 4%
	on a constant basis and same days			-1 . 6%			-2 . 2%
	China	46 . 0	59 . 0	+28 . 2%	76 . 2	101 . 8	+33 . 7%
	on a constant basis and same days			+27 . 6%			+32 . 9%
Gross profit		58 . 1	61 . 8	+6 . 3%	110 . 5	114 . 0	+3 . 2%
	as a % of sales	22 . 1%	21 . 5%	-60bps	22 . 9%	21 . 8%	-110bps
Distribution & adm . expenses (incl . depreciation)		(43 . 4)	(45 . 7)	+5 . 3%	(84 . 8)	(86 . 0)	+1 . 4%
EBITA		14 . 7	16 . 1	+9 . 3%	25 . 7	28 . 0	+9 . 0%
	as a % of sales	5 . 6%	5 . 6%	flat	5 . 3%	5 . 4%	+10bps
Headcount (end of period)		2,671	2,616	-2 . 1%	2,671	2,616	-2 . 1%

Other

- Ricavi netti consolidati E 376,3 milioni, - 0,8% . - Vendite farmaceutiche E 363,4 milioni, - 0,5% . - Utile operativo E 83,8 milioni, + 1,6% . - Utile netto E 59,2 milioni, + 2,5% . - Posizione finanziaria netta*: debito di E 21,0 milioni . - Urorec®/Silodyx® (silodosina) approvato dall European Medicines Agency (E . M . A . ) in Europa . - Carbaglu® (acido carglumico) approvato dall FDA in U . S . A . . - Accordo con Leespharm per la vendita di lercanidipina in Cina . Accordo con Esteve per la vendita di pitavastatina in Spagna . Accordo con Zambon per la vendita di silodosina in Francia . - Acquisizione di ArtMed International S . r . l . in Romania . - Eventi successivi: nel mese di luglio si è conclusa positivamente la Procedura Decentrata per l approvazione di pitavastatina (Livazo®, Alipza® e altri marchi) in Europa . Milano, 28 luglio 2010 - Il Consiglio di Amministrazione della Recordati S . p . A . ha approvato la Relazione finanziaria semestrale al 30 giugno 2010, redatta ai sensi dall art . 154-ter del D . Lgs . 58/1998 e successive modifiche, nonché del Regolamento Emittenti emanato dalla Consob . La relazione è stata predisposta secondo quanto richiesto dallo IAS 34, principio contabile internazionale concernente l informativa finanziaria infrannuale, e redatta utilizzando i principi di valutazione, misurazione ed esposizione stabiliti dagli IAS/IFRS . La relazione finanziaria al 30 giugno 2010 è depositata presso la sede sociale e Borsa Italiana S . p . A . ed è disponibile sul sito internet: http://www . recordati . it/rec_it/investors/reports/ . Principali risultati consolidati- I ricavi consolidati, pari a E 376,3 milioni, sono in leggera diminuzione (-0,8%) rispetto allo stesso periodo dell anno precedente . In particolare, le vendite farmaceutiche ammontano a E 363,4 milioni, in diminuzione dello 0,5% . La scadenza del brevetto di prodotto a protezione del principio attivo lercanidipina nei principali paesi europei nel mese di gennaio ha comportato una riduzione delle vendite del farmaco del 25,1%, quasi integralmente compensata dal buon andamento delle vendite degli altri farmaci e dai proventi per l attività di licenza dei nostri prodotti a livello internazionale . Le vendite della chimica farmaceutica, pari a E 12,9 milioni, sono in contrazione del 9,1% . - L utile operativo è pari a E 83,8 milioni, in incremento dell 1,6% rispetto allo stesso periodo dell anno precedente grazie principalmente alla riduzione delle spese di vendita, generali e amministrative . La sua incidenza sui ricavi è del 22,3% . - L utile netto, pari a E 59,2 milioni (+2,5%), cresce in misura superiore alla redditività operativa per la minore incidenza degli oneri finanziari . - La posizione finanziaria netta* al 30 giugno 2010 evidenzia un debito netto di E 21,0 milioni, in incremento di E 1,2 milioni rispetto al 31 dicembre 2009 . Nel periodo sono stati pagati dividendi per E 54,4 milioni . Il patrimonio netto si è ulteriormente incrementato ed è pari a E 523,3 milioni . * Investimenti finanziari a breve termine e disponibilità liquide, al netto dei debiti verso banche e dei finanziamenti a medio/lungo termine, inclusa la valutazione al fair value degli strumenti derivati di copertura (fair value hedge) . Iniziative per lo sviluppoA fine gennaio la Commissione Europea ha rilasciato l autorizzazione all immissione in commercio delle specialità farmaceutiche Urorec® e Silodyx(TM) (silodosina), per il trattamento dei sintomi dell iperplasia prostatica benigna e, nel mese di giugno, anche la Federazione Russa ha autorizzato la commercializzazione di prodotti a base di silodosina . Nel mese di aprile è stato concluso un accordo di licenza con Zambon France, filiale francese del gruppo farmaceutico italiano Zambon, per la concessione dei diritti di commercializzazione di silodosina in Francia . Zambon lancerà il prodotto con il marchio Silodyx(TM) in co-marketing con Bouchara Recordati che lo commercializzerà con il nome Urorec® . Nel mese di giugno silodosina, con il marchio Urorec®, è stato introdotto nel mercato tedesco . Negli altri mercati europei si prevede di iniziare la commercializzazione del prodotto nel corso dei prossimi mesi, in seguito al completamento delle procedure di ottenimento del prezzo e del rimborso nei singoli paesi europei . Sempre nel mese di gennaio è stato concluso un accordo con Novartis per l acquisizione in Grecia e in altri paesi europei di Lopresor® (metoprololo), un noto farmaco beta bloccante selettivo indicato nel trattamento di varie affezioni cardiovascolari, in particolare ipertensione e angina pectoris . Recordati ha acquisito le registrazioni e il know-how relativo al prodotto, compreso il diritto di fabbricarlo, nonché una licenza illimitata non onerosa sul marchio Lopresor® . Nel 2009 le vendite di Lopresor® (metoprololo) nei paesi coperti dall accordo sono state complessivamente di circa E 4 milioni, la maggior parte delle quali realizzate in Grecia . Nel mese di marzo è stata ottenuta l approvazione, da parte della Food and Drug Administration (FDA) negli Stati Uniti d America, della domanda di autorizzazione all immissione in commercio (NDA), presentata da Orphan Europe, per l utilizzo di Carbaglu® (acido carglumico) nel trattamento dell iperammonemia acuta dovuta al deficit dell enzima epatico N-acetilglutammato sintasi (deficit di NAGS) e nella terapia di mantenimento dell iperammonemia cronica dovuta al deficit di NAGS . Sempre nel mese di marzo è stato siglato con Lee s Pharmaceutical Holdings Ltd un accordo di licenza per la commercializzazione nella Repubblica Popolare Cinese di Zanidip® (lercanidipina) . Nel mese di aprile è stato concluso un accordo di licenza con Esteve, primaria società farmaceutica spagnola, per la commercializzazione in Spagna di pitavastatina, una "statina" innovativa per il trattamento delle ipercolesterolemie . Esteve lancerà il prodotto in co-marketing con Recordati España, filiale iberica del gruppo . La pitavastatina è stata concessa in licenza a Recordati dai laboratori giapponesi Kowa per il mercato europeo . Nel mese di luglio si è conclusa positivamente la Procedura Decentrata per l approvazione di pitavastatina (Livazo®, Alipza® e altri marchi) in Europa . Nel mese di giugno Recordati ha acquisito ArtMed International, società specializzata nella promozione di prodotti farmaceutici in Romania con sede a Bucarest . Sono inoltre stati acquisiti i diritti sui prodotti attualmente promossi in Romania da ArtMed . Il prezzo corrisposto è di E 1,2 milioni, oltre a un earn-out calcolato sull utile lordo dei 5 prodotti che la società ha in licenza . ArtMed ha 24 dipendenti dedicati all attività di marketing e all informazione medico scientifica presso la classe medica e i farmacisti . I farmaci attualmente presentati sono indicati prevalentemente per patologie legate ai deficit di sostanze nutrizionali oltre al Revada® (diosmina) utilizzato nell insufficienza veno-linfatica e in altre indicazioni . Eventi successivi ed evoluzione prevedibile della gestioneNel mese di luglio si è conclusa positivamente la Procedura Decentrata per l approvazione di pitavastatina (Livazo®, Alipza® ed altri marchi) in Europa come comunicato dal Reference Member State (MHRA, Medicines and Healthcare products Regulatory Agency, UK), in seguito all accordo di tutti gli Stati Membri coinvolti (Concerned Member States, CMS) . Pitavastatina, compresse da 1mg, 2mg e 4mg, è indicata per la riduzione dei livelli elevati di colesterolo totale (TC) e colesterolo LDL (LDL-C) in pazienti adulti con ipercolesterolemia primaria e dislipidemia combinata (mista), quando la risposta alla dieta e ad altre misure non farmacologiche è inadeguata . L attività del gruppo è continuata secondo le aspettative nel mese di luglio e per l intero anno 2010 si prevede di realizzare ricavi superiori a E 700 milioni, un utile operativo superiore a E 140 milioni e un utile netto superiore a E 95 milioni . Conference callRecordati organizzerà una conference call oggi 28 luglio alle ore 16 . 00 . Il conference ID è 89131263 e i numeri per poter accedere sono i seguenti:Italia +39 02 36005955UK +44 (0) 1452587427USA 18665516755Francia +33 (0) 170751217Germania +49 (0) 6922227071Le diapositive alle quali si farà riferimento durante la conference call saranno disponibili nel sito www . recordati . it alla voce "Investors", sezione "Presentazioni":http://www . recordati . it/rec_it/investors/presentations/Gli interessati sono pregati di chiamare 10 minuti prima dell inizio indicando la conference ID 89131263 . Per accedere a l assistenza da parte di un operatore digitare *0 oppure chiamare il +44 1452569034 . La registrazione della conference call sarà disponibile nel sito www . recordati . it . Recordati (Reuters RECI . MI, Bloomberg REC IM), fondata nel 1926, è un gruppo farmaceutico europeo, quotato alla Borsa Italiana (ISIN IT 0003828271), con oltre 2 . 800 dipendenti, che si dedica alla ricerca, allo sviluppo, alla produzione e alla commercializzazione di prodotti farmaceutici . Ha sede a Milano, attività operative nei principali paesi europei ed una presenza crescente nei nuovi mercati del centro ed est Europa . Una rete europea di circa 1 . 400 informatori scientifici del farmaco promuove un ampia gamma di farmaci innovativi, sia originali che su licenza, appartenenti a diverse aree terapeutiche compresa un attività specializzata nelle malattie rare . Recordati si propone come partner di riferimento per l acquisizione di nuove licenze per il mercato europeo per quelle aziende che non dispongono di reti commerciali in Europa . Recordati è impegnata nella ricerca e sviluppo di farmaci innovativi per l area cardiovascolare e genito-urinaria, ed anche di terapie per malattie rare . I ricavi consolidati nel 2009 sono stati pari a E 747,5 milioni, l utile operativo è stato pari a E 162,2 milioni e l utile netto è stato pari a E 110,6 milioni . Per ulteriori informazioni:Sito Recordati: www . recordati . itRelazioni con gli investitori Relazioni con i giornalistiMarianne Tatschke Claudio Rossetti (Echo Comunicazione d Impresa)(39)0248787393 (39)0262694736e-mail: inver@recordati . it e-mail: crossetti@echocom . itQuesta comunicazione contiene valutazioni e ipotesi su fatti futuri ("forward-looking statements" nel significato di cui all U . S . Private Securities Litigation Reform Act del 1995) che riflettono la migliore stima in base a quanto attualmente noto . Tali valutazioni e ipotesi, tuttavia, dipendono anche da numerosi fattori esterni, fuori dal controllo della società, e da avvenimenti incerti, che sono soggetti a numerosi rischi . I risultati futuri potrebbero differire anche sensibilmente da quanto espresso o deducibile da questa comunicazione . Le citazioni e descrizioni di "specialità etiche Recordati", soggette a prescrizione medica, vengono date solo per informare gli azionisti sull attività della Società e non hanno alcun intendimento né di promuovere né di consigliare l uso delle specialità stesse . GRUPPO RECORDATISintesi dei risultati consolidati,secondo principi contabili internazionalmente riconosciuti (I . A . S . /I . F . R . S . )(in migliaia di E)

CONTO ECONOMICO	Primo semestre 2010	Primo semestre 2009	Var . %
RICAVI NETTI	376 . 263	379 . 301	(0,8)
Costo del venduto	(121 . 390)	(121 . 257)	0,1
UTILE LORDO	254 . 873	258 . 044	(1,2)
Spese di vendita	(113 . 817)	(115 . 327)	(1,3)
Spese di ricerca e sviluppo	(32 . 867)	(33 . 682)	(2,4)
Spese generali e amministrative	(21 . 326)	(22 . 439)	(5,0)
Altri (oneri)/proventi netti	(3 . 033)	(4 . 096)	(26,0)
UTILE OPERATIVO	83 . 830	82 . 500	1,6
(Oneri)/Proventi finanziari netti	(1 . 383)	(2 . 760)	(49,9)
UTILE PRIMA DELLE IMPOSTE	82 . 447	79 . 740	3,4
Imposte	(23 . 239)	(21 . 999)	5,6
UTILE NETTO DI GRUPPO	59 . 208	57 . 741	2,5
Attribuibile a:
Gruppo	59 . 206	57 . 739	2,5
Azionisti Terzi	2	2	0,0

UTILE NETTO PER AZIONE	Primo semestre 2010	Primo semestre 2009	Var . %
Base	E 0,299	E 0,293	2,0
Diluito	E 0,285	E 0,283	0,7

L utile netto per azione base è calcolato sul numero medio di azioni in circolazione nei rispettivi periodi, pari a n . 197 . 818 . 982 per il 2010 e n . 197 . 089 . 168 per il 2009 . Tali valori sono calcolati deducendo le azioni proprie in portafoglio, la cui media è pari a n . 11 . 306 . 174 per il 2010 e a n . 11 . 472 . 355 per il 2009 . L utile netto per azione diluito è calcolato tenendo conto delle opzioni assegnate ai dipendenti .

COMPOSIZIONE RICAVI NETTI	Primo semestre 2010	Primo semestre 2009	Var . %
Farmaceutico	363 . 380	365 . 126	(0,5)
Chimica farmaceutica	12 . 883	14 . 175	(9,1)
TOTALE	376 . 263	379 . 301	(0,8)
- di cui Internazionali	268 . 905	269 . 126	(0,1)

In corso di verifica da parte della società di revisione . GRUPPO RECORDATISintesi dei risultati consolidati,secondo principi contabili internazionalmente riconosciuti (I . A . S . /I . F . R . S . )(in migliaia di E)

CONTO ECONOMICO	2° trimestre 2010	2° trimestre 2009	Var . %
RICAVI NETTI	190 . 407	195 . 614	(2,7)
Costo del venduto	(61 . 691)	(61 . 099)	1,0
UTILE LORDO	128 . 716	134 . 515	(4,3)
Spese di vendita	(58 . 494)	(60 . 470)	(3,3)
Spese di ricerca e sviluppo	(16 . 439)	(18 . 382)	(10,6)
Spese generali e amministrative	(10 . 893)	(11 . 521)	(5,5)
Altri (oneri)/proventi netti	(2 . 135)	(2 . 277)	(6,2)
UTILE OPERATIVO	40 . 755	41 . 865	(2,7)
(Oneri)/Proventi finanziari netti	(603)	(1 . 309)	(53,9)
UTILE PRIMA DELLE IMPOSTE	40 . 152	40 . 556	(1,0)
Imposte	(10 . 918)	(10 . 434)	4,6
UTILE NETTO DI GRUPPO	29 . 234	30 . 122	(2,9)
Attribuibile a:
Gruppo	29 . 232	30 . 121	(3,0)
Azionisti Terzi	2	1	100,0

COMPOSIZIONE RICAVI NETTI	2° trimestre 2010	2° trimestre 2009	Var . %
Farmaceutico	183 . 753	188 . 322	(2,4)
Chimica farmaceutica	6 . 654	7 . 292	(8,7)
TOTALE	190 . 407	195 . 614	(2,7)
- di cui Internazionali	139 . 486	140 . 961	(1,0)

In corso di verifica da parte della società di revisione . GRUPPO RECORDATISintesi dei risultati consolidati,secondo principi contabili internazionalmente riconosciuti (I . A . S . /I . F . R . S . )(in migliaia di E)

ATTIVITA	30 . 06 . 2010	31 . 12 . 2009
Immobilizzazioni materiali	53 . 468	55 . 381
Attività immateriali	112 . 323	96 . 512
Avviamento	308 . 742	303 . 653
Altre partecipazioni e titoli	3 . 724	3 . 716
Crediti	3 . 884	3 . 804
Attività fiscali differite	20 . 106	21 . 793
TOTALE ATTIVITA NON CORRENTI	502 . 247	484 . 859
Rimanenze di magazzino	88 . 228	86 . 627
Crediti commerciali	132 . 602	132 . 621
Altri crediti	22 . 291	22 . 990
Altre attività correnti	5 . 642	2 . 607
Strumenti derivati valutati al fair value (fair value hedge)	5 . 762	0
Investimenti finanziari a breve termine e disponibilità liquide	66 . 263	93 . 775
TOTALE ATTIVITA CORRENTI	320 . 788	338 . 620
TOTALE ATTIVITA	823 . 035	823 . 479

PATRIMONIO NETTO E PASSIVITA	30 . 06 . 2010	31 . 12 . 2009
Capitale sociale	26 . 141	26 . 141
Riserva sovrapprezzo azioni	83 . 719	83 . 719
Azioni proprie	(55 . 129)	(59 . 103)
Riserva per strumenti derivati valutati al fair value	(5 . 406)	(4 . 040)
Differenza da conversione dei bilanci in valuta estera	813	(6 . 178)
Altre riserve	25 . 549	25 . 025
Utili indivisi	388 . 400	332 . 836
Utile del periodo	59 . 206	110 . 560
PATRIMONIO NETTO DI GRUPPO	523 . 293	508 . 960
Patrimonio netto di terzi	21	19
PATRIMONIO NETTO	523 . 314	508 . 979
Finanziamenti	87 . 579	79 . 990
Fondo trattamento di fine rapporto e altri benefici	19 . 408	19 . 895
Passività per imposte differite	5 . 508	5 . 661
Altri debiti	5 . 713	6 . 179
TOTALE PASSIVITA NON CORRENTI	118 . 208	111 . 725
Debiti commerciali	89 . 540	81 . 751
Altri debiti	51 . 081	48 . 406
Debiti tributari	8 . 240	12 . 555
Altre passività correnti	632	517
Fondi per rischi e oneri	21 . 187	21 . 978
Strumenti derivati valutati al fair value (cash flow hedge)	5 . 406	4 . 040
Strumenti derivati valutati al fair value (fair value hedge)	0	2 . 257
Quote correnti di finanziamenti a medio/lungo termine	1 . 298	2 . 419
Debiti verso banche e altri	4 . 129	28 . 852
TOTALE PASSIVITA CORRENTI	181 . 513	202 . 775
TOTALE PATRIMONIO NETTO E PASSIVITA	823 . 035	823 . 479

In corso di verifica da parte della società di revisione . DICHIARAZIONE DEL DIRIGENTE PREPOSTO ALLA REDAZIONE DEI DOCUMENTI CONTABILI SOCIETARIIl dirigente preposto alla redazione dei documenti contabili societari Fritz Squindo dichiara, ai sensi del comma 2 articolo 154 bis del Testo Unico della Finanza, che l informativa contabile contenuta nel presente comunicato, corrisponde alle risultanze documentali, ai libri ed alle scritture contabili . Copyright HuginThe appendixes relating to the press release are available on: http://www . hugingroup . com/documents_ir/PJ/CO/2010/168739_88_8061_Risultatiprimosemestre2010 . doc Questo comunicato é distribuito da Hugin . L emittente è l unico responsabile per il contenuto del comunicato . [CN#168739]